431.42USD-0.32%Mkt Cap: 12.27B USDP/E: 27.06Last update: 2026-05-26
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap12.27B USD
Enterprise Value11.78B USD
Revenue (TTM)2.68B USD
Gross Profit760.62M USD
Net Income (TTM)451.12M USD
Revenue/Share94.44 USD
Last Price431.42 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6.3K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS58506Q1094
Valuation
P/E (Trailing)27.06
P/E (Forward)23.17
PEG2.59
EV/EBITDA19.93
EV/Revenue4.40
P/S4.59
P/B20.53
EPS (TTM)15.87
EPS (Forward)18.56
52W Range
287.1742% of range628.92
52W High628.92 USD
52W Low287.17 USD
Profitability
Gross Margin30.06%
Oper. Margin20.03%
EBITDA Margin22.07%
Profit Margin17.83%
ROE98.27%
ROA22.84%
Growth
Revenue Growth26.50%
Earnings Growth16.60%
Cash Flow & Leverage
Operating CF713.22M USD
CapEx (TTM)31.36M USD
FCF Margin18.32%
FCF Yield4.00%
Net Debt-506.59M USD
Net Debt/EBITDA-0.86
Balance Sheet
Debt/Equity0.25
Current Ratio0.85
Quick Ratio0.78
Book Value/Sh20.95 USD
Cash/Share22.85 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.5 (Hold)
Target (Mean)442.83 USD
Target Range329.00 USD – 495.00 USD
# Analysts12
Ownership
Shares Out.28.56M
Float23.00M
Insiders19.42%
Institutions88.91%
Short Interest
Short Ratio3.3d
Short % Float6.74%
Short % Out.5.43%
Shares Short1.55M
Short (prev mo.)1.22M
Technical
SMA 50456.99 (-5.6%)
SMA 200512.97 (-15.9%)
Beta1.19
S&P 52W Chg28.31%
Avg Vol (30d)444.89K
Avg Vol (10d)336.54K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—